Cambridge Healthtech Institute’s Inaugural

Emerging Technologies for Discovery Chemistry

Covalent Approaches and New Biophysical Tools

April 15 - 16, 2025 ALL TIMES PDT

CHI's Inaugural Emerging Technologies for Discovery Chemistry conference convenes medicinal, biophysical, and structural chemists to strategize and learn from one another about deploying the latest biophysical technologies for new small molecule drug-lead generation. Covalent strategies, cryoEM, and innovations in biophysical screening applications such as the use of Affinity-Selection Mass Spectrometry (AS-MS), will be the focus. Join us to learn about scientists continually adapting technologies to keep pace with drug discovery innovations such as Targeted-Protein Degradation (TPD) strategies, applications of proteomics and DNA-Encoded Libraries (DEL) for small molecule screening and cryoEM for the design of new chemical entities against membrane targets.

For more details on the conference, please contact:

Anjani Shah, PhD

Senior Conference Director and Lead Content Director for Drug Discovery Chemistry

Cambridge Healthtech Institute

Phone: (+1) 781-247-6252

Email: ashah@healthtech.com

For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431

Email: kskahan@healthtech.com